Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where İlter Alkan is active.

Publication


Featured researches published by İlter Alkan.


The Journal of Urology | 1997

Reactive Oxygen Species Production by the Spermatozoa of Patients With Idiopathic Infertility: Relationship to Seminal Plasma Antioxidants

İlter Alkan; Ferruh Simsek; Goncagül Haklar; Ertan Kervancioglu; Hakan Özveri; Suha Yalcin; Atif Akdas

PURPOSE We attempted to determine reactive oxygen species production by the spermatozoa of patients with idiopathic infertility and healthy donors, and observe whether increased production was due to decreased seminal plasma reactive oxygen species scavengers. MATERIALS AND METHODS Reactive oxygen species production by spermatozoa and seminal plasma antioxidants was assayed in 18 patients with idiopathic infertility and 10 controls. Reactive oxygen species formation and seminal plasma antioxidants were measured by luminol and lucigenin dependent chemoluminescence, and enzymatic methods, respectively. RESULTS Higher reactive oxygen species production was observed in 16 of the 18 patients (88.8%, p < 0.0001 versus controls). Seminal plasma superoxide dismutase, catalase, glutathione peroxidase and total sulfhydryl group levels in infertile patients were significantly lower than in controls. CONCLUSIONS Decreased seminal plasma antioxidant activity and increased reactive oxygen species production can be responsible for idiopathic male infertility.


International Urology and Nephrology | 1996

Volume determinations by transrectal ultrasonography in patients with benign prostatic hyperplasia: Correlation with removed prostate weight

İlter Alkan; Levent Türkeri; T. Biren; I. Çevik; Atif Akdas

Estimation of prostate gland volume with transrectal ultrasonography (TRUS) provides important information in the evaluation of benign and malignant prostate disease. We evaluated 119 patients with clinically benign prostatic hyperplasia (BPH) by TRUS. Sixty-eight of these underwent transurethral resection of the prostate (TUR-P), and 51 patients underwent open prostatectomy. In both groups the estimated weight correlated well with the removed prostatic weight (r=0.643, p<0.0001 in TUR-P and r=0.729, p<0.0001 in open prostatectomy). We found that TRUS is a valuable method for estimation of prostatic volume in patients with BPH.


International Braz J Urol | 2016

Holmium laser enucleation of the prostate: surgical, functional, and quality-of-life outcomes upon extended follow-up

İlter Alkan; Hakan Özveri; Yigit Akin; Tumay Ipekci; Yusuf Alican

ABSTRACT Objectives: To evaluate the long-term surgical, functional, and quality-of-life (QoL) outcomes after Holmium laser enucleation of the prostate (HoLEP) in patients with symptomatic benign prostatic hyperplasia (BPH). Materials and Methods: We retrospectively reviewed recorded data on patients who underwent HoLEP between June 2002 and February 2005. Ninety-six patients were enrolled. Demographic, perioperative, and postoperative data were recorded. On follow-up, International Prostate Symptom Scores (IPSSs), prostate-specific antigen (PSA) levels, QoL scores, peak uroflowmetric data (Qmax values), and post-voiding residual urine volumes (PVR volumes), were recorded. Complications were scored using the Clavien system. Statistical significance was set at p<0.05. Results: The mean follow-up time was 41.8±34.6 months and the mean patient age 73.2±8.7 years. The mean prostate volume was 74.6±34.3mL. Significant improvements in Qmax values, QoL, and IPSSs and decreases in PSA levels and PVR volumes were noted during follow-up (all p values=0.001). The most common complication was a requirement for re-catheterisation because of urinary retention. Two patients had concomitant bladder tumours that did not invade the muscles. Eight patients (8.3%) required re-operations; three had residual adenoma, three urethral strictures, and two residual prostate tissue in the bladder. Stress incontinence occurred in one patient (1%). All complications were of Clavien Grade 3a. We noted no Clavien 3b, 4, or 5 complications during follow-up. Conclusions: HoLEP improved IPSSs, Qmax values, PVR volumes, and QoL and was associated with a low complication rate, during extended follow-up. Thus, HoLEP can be a viable option to transurethral resection of the prostate.


Urologia Journal | 2018

Serum procalcitonin levels in prostate cancer: A new biomarker?

Lutfi Canat; Hasan Anıl Atalay; Osman Can; İlter Alkan; Alper Otunctemur

Background: To examine the role of serum procalcitonin as a biomarker for the detection of prostate cancer in patients with a serum prostate-specific antigen less than 20.0 ng/mL. Methods: The prospective study included patients with a prostate-specific antigen level of 2–20 ng/mL, who underwent prostate biopsy. Clinical and pathological data such as age, prostate volume, prostate-specific antigen, procalcitonin, and Gleason score were reviewed. All patients were divided into three groups with total prostate-specific antigen level between 2 and 4 ng/mL, 4.1 and 10 ng/mL, and 10.1 and 20 ng/mL. Results: Of 227 patients who underwent biopsy, prostate cancer was diagnosed in 74 (32.6%) patients and the remaining 153 patients had a benign condition. The difference in mean serum procalcitonin values was significantly higher in the prostate cancer compared with the benign group (0.06 ± 0.03 vs 0.04 ± 0.03 ng/mL; p = 0.0001). Using a threshold of 0.045 ng/mL, procalcitonin was 54.1% sensitive and 80.3% specific (area under curve = 0.683). Serum procalcitonin levels were not able to differentiate between prostate cancer patients with prostate-specific antigen level of 2–4, 4.1–10, and 10.1–20 ng/mL. Conclusion: Based on this prospective study, procalcitonin can be a novel supplementary biomarker to increase the accuracy of prostate cancer screening.


Akdeniz Medical Journal | 2017

Preoperatif Nötrofil Lenfosit Oranının Açık Prostatektomi Yapılan Benign Prostat Hiperplazili Hastalarda Perioperatif Sonuçlara Etkisi

Erhan Ateş; Yigit Akin; Tümay Ipekçi; Eyyüp Sabri Pelit; İlter Alkan; Halil Ciftci; Ercan Yeni

E-mail: [email protected] 1Xxxxxxxxxxxxx 2Xxxxxxxxxxxxx Erhan ATEŞ1, Yiğit AKIN2, Tümay İPEKÇİ3, Eyyüp Sabri PELİT4, İlter ALKAN5, Halil ÇİFTÇİ4, Ercan YENİ4 Impact of Preoperative Neutrophil to Lymphocyte Ratio in Patients with Benign Prostate Hyperplasia Undergo Open Prostatectomy: A Pilot Study Preoperatif Nötrofil Lenfosit Oranının Açık Prostatektomi Yapılan Benign Prostat Hiperplazili Hastalarda Perioperatif Sonuçlara Etkisi


International Urology and Nephrology | 2014

Rare cause of adult female incontinence: complete duplication of the collecting system and ectopic ureter of the kidney draining into the vagina treated by laparoscopic upper pole heminephrectomy and ureterectomy

İlter Alkan; Hakan Özveri; Selim Taş; Tumay Ipekci; Serdar Yilmaz

A 38-year-old woman presented with a lifelong history of involuntary urinary leakage. The patient reported that she had been operated for her urinary leakage with the diagnosis of stress incontinence with transobturator tape two times at two different institutions. Preoperative computed tomography scan showed complete duplication of the left kidney with poorly functioning upper pole and a tortuous left dilated ureter running down and opening into the vagina. Laparoscopic left upper pole heminephrectomy and ureterectomy were performed uneventfully. Her incontinence improved immediately after surgery.


International Braz J Urol | 2017

Impact of personalized three-dimensional (3D) printed pelvicalyceal system models on patient information in percutaneous nephrolithotripsy surgery: a pilot study

Hasan Anıl Atalay; H. Lütfi Canat; Volkan Ülker; İlter Alkan; Ünsal Özkuvanci; Fatih Altunrende


Urological Research | 2018

Evaluation of stone volume distribution in renal collecting system as a predictor of stone-free rate after percutaneous nephrolithotomy: a retrospective single-center study

Hasan Anıl Atalay; Lutfi Canat; Recep Bayraktarlı; İlter Alkan; Osman Can; Fatih Altunrende


The Medical Journal of Okmeydanı Training and Research Hospital | 2018

Platelet-to-lymphocyte ratio is an independent prognostic factor in clinically non-metastatic renal cell carcinoma

Lutfi Canat; Samir Agalarov; Fatih Akkaş; Hasan Anıl Atalay; İlter Alkan; Suleyman Sami Cakir; Fatih Altunrende; Alper Otunctemur


The Journal of Urology | 2018

MP15-02 SEMEN REACTIVE OXYGEN SPECIES LEVELS IN PATIENTS WITH CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME CATEGORY IIIA: RELATIONSHIP WITH THE NATIONAL INSTITUTES OF HEALTH-CHRONIC PROSTATITIS SYMPTOM INDEX

İlter Alkan; Meral Yüksel; Anıl Atalay; Lutfi Canat; çigdem Arabaci; Muammer Bozkurt; M. Murad Basar

Collaboration


Dive into the İlter Alkan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge